tiprankstipranks
Trending News
More News >
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
:GPCR
US Market

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership - Who Owns Structure Therapeutics, Inc. Sponsored ADR?

Compare
1,002 Followers

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Ownership Overview

11.67%35.25%43.64%1.00%8.43%
11.67% Insiders
43.64% Other Institutional Investors
1.00% ETFs
8.43% Public Companies and Individual Investors
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 79.89% of the company’s stock is owned by Institutional Investors, 11.67% is owned by Insiders, and 8.43% is owned by Public Companies and Individual Investors.
The ownership structure of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is a mix of institutional, retail, and individual investors. Approximately 78.89% of the company’s stock is owned by Institutional Investors, 11.67% is owned by Insiders, and 1.00% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 05, 2024
xxxxxxxxxxxxx
$5600988

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$73515

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,436,286Institution7.71%108,378,467
4,249,142Institution7.39%103,806,539
2,847,885Insider4.95%69,573,831
2,688,264Insider4.67%65,674,290
1,517,418Institution2.64%37,070,522
1,484,467Institution2.58%36,265,529
1,458,288Institution2.53%35,625,976
1,272,743Institution2.21%31,093,111
1,115,559Institution1.94%27,253,106
929,176Institution1.61%22,699,770

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,436,286Institution7.71%108,378,467
4,249,142Institution7.39%103,806,539
1,484,467Institution2.58%36,265,529
1,458,288Institution2.53%35,625,976
1,115,559Institution1.94%27,253,106
929,176Institution1.61%22,699,770
740,102Institution1.29%18,080,692
678,434Institution1.18%16,574,143
582,447Institution1.01%14,229,180
515,429Institution0.90%12,591,930

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
236,412Institution0.41%5,775,545
58,128Institution0.10%1,384,318
42,628Institution0.07%1,041,402
41,336Institution0.07%715,526
38,249Institution0.07%910,900
27,914Institution0.05%664,772
23,904Institution0.04%569,274
16,449Institution0.03%284,732
15,000Institution0.03%585,063
13,022Institution0.02%318,127

FAQ

Who Owns Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
According to the latest TipRanks data, approximately 43.64% of the company's stock is held by institutional investors, 11.67% is held by insiders, and 8.43% is held by retail investors.
    What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 43.64% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by institutional investors.
      What percentage of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 8.43% of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock is held by retail investors.
        Who owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR)?
        SMALLCAP World Fund Inc owns the most shares of Structure Therapeutics, Inc. Sponsored ADR (GPCR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis